Winner Medical Co., Ltd. (SHE:300888)

Winner Medical Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Cash & Equivalents	1,265	1,412	4,706	4,527	4,274	4,163
Short-Term Investments	-	340.99	-	101.67	50.16	-
Trading Asset Securities	2,268	2,921	2,850	4,379	3,131	4,131
Cash & Short-Term Investments	3,533	4,674	7,556	9,007	7,455	8,294
Cash Growth	-43.76%	-38.14%	-16.11%	20.83%	-10.12%	1624.84%
Accounts Receivable	1,181	1,088	845.29	1,077	785.49	862.5
Other Receivables	191.56	186.35	218.91	236.3	329.18	458.17
Receivables	1,373	1,274	1,064	1,313	1,115	1,321
Inventory	1,958	1,958	1,434	1,559	1,597	1,216
Other Current Assets	630.1	174.79	501.14	246.61	179.06	159.22
Total Current Assets	7,494	8,081	10,556	12,126	10,346	10,990
Property, Plant & Equipment	5,034	5,024	4,151	3,550	2,225	1,462
Long-Term Investments	546.76	553.26	90.88	61.75	16.95	13.42
Goodwill	1,251	1,251	864.29	1,045	-	-
Other Intangible Assets	1,072	1,096	995.23	1,033	265.7	208.33
Long-Term Accounts Receivable	-	31.21	35.69	-	-	-
Long-Term Deferred Tax Assets	135.25	139	175.35	211.97	122.72	143.13
Long-Term Deferred Charges	133.9	143.86	131.09	132.69	174.79	121.34
Other Long-Term Assets	2,122	2,072	112.55	92.27	115.57	63.81
Total Assets	17,789	18,392	17,112	18,253	13,267	13,002
Accounts Payable	1,285	1,588	1,433	1,144	770.72	756
Accrued Expenses	204.51	525.58	530.34	714.42	448.46	264.91
Short-Term Debt	1,798	1,969	1,493	2,295	-	150.07
Current Portion of Long-Term Debt	204.67	175.11	20.14	8.01	-	-
Current Portion of Leases	-	215.05	202.66	207.31	216.18	-
Current Income Taxes Payable	116.49	82.32	40.19	197.57	80.63	415.53
Current Unearned Revenue	178.85	182.76	193.26	566.82	341.18	684.5
Other Current Liabilities	632.59	533.92	358.47	353.78	217.57	155.77
Total Current Liabilities	4,421	5,272	4,271	5,487	2,075	2,427
Long-Term Debt	107.58	101.54	170	-	-	-
Long-Term Leases	409.31	440.88	292.01	326.46	381.81	-
Long-Term Unearned Revenue	160.36	157.15	121.65	98.79	109.63	94.92
Long-Term Deferred Tax Liabilities	158.23	158.52	138.52	133.68	13.34	12.17
Other Long-Term Liabilities	373.26	377.48	-	-	-	-
Total Liabilities	5,643	6,516	5,002	6,055	2,580	2,534
Common Stock	582.33	582.33	594.39	426.49	426.49	426.49
Additional Paid-In Capital	3,393	3,379	4,381	4,546	4,550	4,482
Retained Earnings	7,449	7,200	7,029	7,246	5,958	5,547
Treasury Stock	-7.28	-7.28	-473.55	-500.08	-257.99	-
Comprehensive Income & Other	-4.76	-2.64	2.22	0.78	-1.56	-1.11
Total Common Equity	11,412	11,151	11,533	11,720	10,675	10,454
Minority Interest	734.07	724.39	577.1	478.16	12.2	14.46
Shareholders' Equity	12,146	11,876	12,110	12,198	10,687	10,468
Total Liabilities & Equity	17,789	18,392	17,112	18,253	13,267	13,002
Total Debt	2,520	2,902	2,178	2,837	597.99	150.07
Net Cash (Debt)	1,013	1,773	5,378	6,170	6,857	8,144
Net Cash Growth	-77.00%	-67.04%	-12.84%	-10.01%	-15.80%	3574.47%
Net Cash Per Share	1.74	3.03	9.08	10.43	11.50	14.95
Filing Date Shares Outstanding	578.06	582.33	583.94	587.63	587.63	597.09
Total Common Shares Outstanding	578.06	582.33	588.14	587.63	587.63	597.09
Working Capital	3,074	2,810	6,285	6,638	8,271	8,563
Book Value Per Share	19.74	19.15	19.61	19.94	18.17	17.51
Tangible Book Value	9,089	8,804	9,674	9,642	10,409	10,246
Tangible Book Value Per Share	15.72	15.12	16.45	16.41	17.71	17.16
Land	-	2.69	-	-	-	-
Buildings	-	2,406	1,967	1,496	949.42	878.49
Machinery	-	2,389	1,983	1,863	1,238	1,119
Construction In Progress	-	1,075	984.57	765.01	216.1	61.38

Source: S&P Global Market Intelligence. Standard template. Financial Sources.